SESSION TITLE: COPD Diagnosis & Evaluation Posters
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM
PURPOSE: To study the change in levels of inflammatory and nutritional markers in AECOPD and correlate them with clinical and laboratory indices of recovery.
METHODS: Serum levels of Leptin, Pre-albumin and Tumor Necrosis Factor α (TNF- α) were estimated in hospitalized AECOPD patients within 48 hours of hospitalized and pre discharge.
RESULTS: 82 patients were evaluated with a mean (SD) age of 61.6 (10.1) years. The median (range) hospital stay and pack years of smoking were 13 (1-77) days and 15 (0-80) respectively. The mean (SD) duration of COPD and duration of current symptoms were 9.6 (1.8) and 9.1(8.6) days respectively. 46 patients (59%) required ventilation with a median (range) duration of 6 (1-34) days. The mean (SD) APACHE score and BMI were 17.6 (5.2) and 23.4 (15.3) respectively. Baseline serum leptin, pre-albumin and TNF- α levels were elevated. Significant improvement in leptin and pre-albumin were observed between admission and hospital discharge. Moreover, significant improvement occurred in respiratory rate, dyspnea, PCO2, hemoglobin, TLC, urea, creatinine, potassium, albumin, and SGPT. Change in Pre-albumin levels correlated significantly with duration of ventilation and duration of hospital stay.
CONCLUSIONS: Serum Prealbumin is a potentially useful marker for monitoring response in AECOPD. The role of Leptin and TNF- α requires further evaluation.
CLINICAL IMPLICATIONS: Serum Pre-albumin may be simple routinely performed investigation to monitor the clinical course of AECOPD
DISCLOSURE: The following authors have nothing to disclose: Kriti Upadhyay, Arvind Uniyal, Randeep Guleria, Dharmender Prasad, Alpana Sharma, R. Pandey, Anant Mohan
No Product/Research Disclosure Information